OasisLMS

Provided by the American Epilepsy Society
Release Date: October 31, 2025
Expiration Date: October 31, 2028

Overview
Self-Assessment in Epilepsy (SAE) Volume is designed to assist members in fulfilling their Continuing Certification requirement to participate in a self-assessment activity. SAE Volume 11 can also be used as a study tool for the subspecialty certifying examination.

This activity consists of 100 questions that test the learner’s knowledge and competence. Feedback on each question is provided immediately following the question, along with references, and peer benchmarking data is provided once the learner completes all 100 questions. The learner does not have to complete all questions at once but can “bookmark” their place in the activity.

The purpose of self-assessment is to provide a basis for selecting focused continuing medical education, lifelong learning, and/or career development. Please see the Learning Objectives below for information on the specific topics covered in this activity.

Following participation in this activity, learners should be able to:

1.) Self-assess their knowledge and competence regarding:

• Basic mechanisms of the epilepsies
• Clinical presentation of the disorder
• Differential diagnosis
• Classification of seizures and epilepsies
• Diverse etiologies of the epilepsies
• Appropriate diagnostic evaluation and test selection
• Principles of management
• System-based practice issues
• Specific needs of subpopulations with epilepsy
• Benchmark their individual results against aggregate peer results on the questions

2.) Self-reflect and utilize their results as the basis for the selection of additional educational activities and/or resources for further study.

The American Epilepsy Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Epilepsy Society designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Credits
The American Medical Association has determined that non-US. licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 8.0 hours of Category 1 credit for completing this program.

Continuing Certification
The American Board of Psychiatry and Neurology has reviewed the Self-Assessment in Epilepsy (SAE) Volume 10 activity and has approved this program as part of a comprehensive self-assessment program, which is mandated by the ABMS as a necessary component of Continuing Certification (CC).

If you have any questions regarding CC, please contact the American Board of Psychiatry and Neurology at: questions@abpn.com or their CC Helpline at 847.229.6512 for more information.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with an ineligible company. Unless otherwise indicated (*), none of the planners or faculty of this activity have any financial relationships to disclose. All relevant financial relationships with ineligible companies have been mitigated. The following individuals contributed to this activity’s content. Update for all courses this year.

Planning Committee Members

Ernesto Gonzalez-Giraldo, MD
Jessical Fesler, MD, MEd
JoJo Yang, MD 
Qian-Zhou (JoJo) Yang, MD 

Faculty/Question Writers

CME Reviewers
Hai Chen, MD, PhD
Tatyana Gitlevich, MD, FAES
Abeer Hani, MD
Casandra Mateo, MD, FAES
Sarah Schmit, MD, FAES
Thitiwan Simasathein, MD
Fahd Sultan, MD, FAES

Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.

Disclaimer
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational and/or experimental uses.

CME Information
In order to receive your CME certificate, you must successfully complete all 100 questions in the activity and submit the completed evaluation.

Contact Information
For further information or assistance with this activity contact the American Epilepsy Society at education@aesnet.org or call 312.883.3800.